[1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017 pii: HYP.0000000000000065.]Search in Google Scholar
[2. Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens Suppl. 1991;9(8):S42-4.]Search in Google Scholar
[3. Karadag B, Ozyigit T, Serindag Z, Ilhan A, Ozben B. Blood pressure profile is associated with microalbuminuria and retinopathy in hypertensive nondiabetic patients. Wien Klin Wochenschr. 2017. DOI: 10.1007/s00508-017-1270-3. (Epub ahead of print). DOI: 10.1007/s00508-017-1270-310.1007/s00508-017-1270-3.(Epubaheadofprint).DOI:10.1007/s00508-017-1270-3]Open DOISearch in Google Scholar
[4. Tsivgoulis G, Pikilidou M, Katsanos AH, Stamatelopoulos K, Michas F, Lykka A et al. Association of ambulatory blood pressure monitoring parameters with the Framingham Stroke Risk Profile. J Neurol Sci. 2017;380:106-111. DOI: 10.1016/j.jns.2017.07.00710.1016/j.jns.2017.07.00728870547]Open DOISearch in Google Scholar
[5. Sekizuka H, Osada N, Akashi YJ. The factors affecting the non-dipper pattern in japanese patients with severe obstructive sleep apnea. Intern Med. 2018;57(11):1553-9. DOI: 10.2169/internalmedicine.0029-1710.2169/internalmedicine.0029-17602866529321408]Open DOISearch in Google Scholar
[6. Cachofeiro V, Miana M, Heras N, Martin-Fernandez B, Ballesteros S, Balfagon G, et al. Inflammation: a link between hypertension and atherosclerosis. Curr Hypertens Rev. 2009;5(1):40-8. DOI: 10.2174/15734020978731433310.2174/157340209787314333]Search in Google Scholar
[7. Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ et al. – Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling and injury. Ann Rev Physiol. 2011;73:479-501. DOI: 10.1146/annurev-physiol-012110-14225010.1146/annurev-physiol-012110-142250386464321054166]Open DOISearch in Google Scholar
[8. Rathcke CN, Vestergaard H. YKL-40 – an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol. 2009;8:61. DOI: 10.1186/1475-2840-8-6110.1186/1475-2840-8-61278905019930630]Search in Google Scholar
[9. Wang Y, Ripa RS, Johansen JS, Gabrielsen A, Steinbruchel DA, Friis T, et al. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J. 2008;42(5):295–302. DOI: 10.1080/1401743080222056710.1080/1401743080222056718615353]Open DOISearch in Google Scholar
[10. Kastrup J, Johansen JS, Winkel P, Hansen JF, Hildebrandt P, Jensen GB, et al. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J. 2009;30(9):1066–72. DOI: 10.1093/eurheartj/ehp04910.1093/eurheartj/ehp04919270316]Search in Google Scholar
[11. Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis. 2007;18(5):391–6. DOI: 10.1097/MCA.0b013e328241d99110.1097/MCA.0b013e328241d99117627189]Open DOISearch in Google Scholar
[12. Henningsen KM, Therkelsen SK, Johansen JS, Bruunsgaard H, Svendsen JH. Plasma YKL-40, a new biomarker for atrial fibrillation? Europace. 2009;11(8):1032–6. DOI: 10.1093/europace/eup10310.1093/europace/eup10319411674]Search in Google Scholar
[13. Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull. 2006;53(2):172-209.]Search in Google Scholar
[14. Xu T, Zhong C, Wang A, Guo Z, Bu X, Zhou Y, et al. YKL-40 Level and hypertension incidence: a population-based nested. case-control study in China. J Am Heart Assoc. 2016;5(11):e004534. DOI: 10.1161/JAHA.116.00453410.1161/JAHA.116.004534]Open DOISearch in Google Scholar
[15. Churakova E, Shubina A; Bolotina, M, Masenko V, Karpov Y. New inflammatory marker YKL-40 is associated with early renal function decline in hypertensive patients with concomitant coronary artery disease and type 2 diabetes mellitus. J Hypertens. 2017;35, e-Supplement 2.10.1097/01.hjh.0000523731.32619.fd]Search in Google Scholar
[16. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framing-ham Offspring Study. Circulation. 2004;110(4):380-5. DOI: 10.1161/01.CIR.0000136581.59584.0E10.1161/01.CIR.0000136581.59584.0]Open DOISearch in Google Scholar
[17. Shu HS, Tai YY, Chang KT, Chu CY, Hsu PC, Ho-Ming Su, et al. Plasma high-sensitivity C-reactive protein level is associated with impaired estimated glomerular filtration rate in hypertensives. Acta Cardiol Sin 2015;31(2):91-7.]Search in Google Scholar
[18. Buyukkaya E, Erayman A, Karakas E, Bugra Nacar A, Kurt M, Buyukkaya S, et al – Relation of red cell distribution width with dipper and non-dipper hypertension. Med Glas (Zenica) 2016;13(2):75-81.]Search in Google Scholar
[19. Pius-Sadowska E, Machaliński B. BDNF - A key player in cardiovascular system. J Mol Cell Cardiol. 2017;110:54-60. DOI: 10.1016/j.yjmcc.2017.07.007. DOI: 10.1016/j.yjmcc.2017.07.00710.1016/j.yjmcc.2017.07.007.DOI:10.1016/j.yjmcc.2017.07.007]Open DOISearch in Google Scholar
[20. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hyper-tens. 2002;15 (2 Pt 1):111–8. DOI: 10.1016/S0895-7061(01)02251-810.1016/S0895-7061(01)02251-8]Search in Google Scholar
[21. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 2013;34(28):2159–219. DOI: 10.1093/eurheartj/eht15110.1093/eurheartj/eht15123771844]Open DOISearch in Google Scholar
[22. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24(6):793-801. DOI: 10.1161/01.HYP.24.6.79310.1161/01.HYP.24.6.7937995639]Open DOISearch in Google Scholar
[23. Niiranen TJ, Jula AM, Kantola IM, Reunanen A. Comparison of agreement between clinic and home-measured blood pressure in the Finnish population: the Finn-HOME Study. J Hypertens. 2006;24(8):1549-55. DOI: 10.1097/01.hjh.0000239290.94764.8110.1097/01.hjh.0000239290.94764.8116877957]Search in Google Scholar
[24. Liu X, Liu C, Schenck H, Yi X, Wang H, Shi x. The risk factors of 9-year follow-up on hypertension in middle-aged people in Tujia-Nationality settlement of China. J Hum Hypertens. 2017;31(12):838-42. DOI: 10.1038/jhh.2017.5810.1038/jhh.2017.58568041428795685]Open DOISearch in Google Scholar
[25. Habibzadeh F, Habibzadeh P, Yadollahi M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med (Zagreb). 2016; 26(3): 297–307. DOI: 10.11613/BM.2016.03410.11613/BM.2016.034508221127812299]Search in Google Scholar
[26. Jimenez MC, Rexrode KM, Kotler G, Everett BM, Glynn RJ, Lee IM et al. Association between markers of inflammation and total stroke by hypertensive status among women. Am J Hypertens. 2016;29(9):1117-24. DOI: 10.1093/ajh/hpw05010.1093/ajh/hpw050497822827235695]Open DOISearch in Google Scholar
[27. Pierdomenico SD, Pierdomenico AM, Coccina F, Lapenna D, Porreca E. Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients. Hypertens Res. 2016;39(11):805–11. DOI: 10.1038/hr.2016.7410.1038/hr.2016.74]Open DOISearch in Google Scholar
[28. Pierdomenico SD, Pierdomenico AM, Di Tommaso R, Coccina F, Di Carlo S, Ettore Porreca E, et al. Morning blood pressure surge, dipping, and risk of coronary events in elderly treated hypertensive patients. Am J Hypertens. 2016;29(1):39-45. DOI: 10.1093/ajh/hpv07410.1093/ajh/hpv074]Open DOISearch in Google Scholar
[29. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62(5):397-408. DOI: 10.1016/j.jacc.2013.05.01610.1016/j.jacc.2013.05.016]Open DOISearch in Google Scholar
[30. Tosu AR, Demir S, Selcuk M, Kaya Y, Akyol A, Ozdemir M, et al. Comparison of inflammatory markers in non-dipper hypertension vs. dipper hypertension and in normotensive individuals: uric acid, C-reactive protein and red blood cell distribution width readings. Postepy Kardiol Interwencyjnej. 2014;10(2): 98–103. DOI: 10.5114/pwki.2014.4351410.5114/pwki.2014.43514]Open DOISearch in Google Scholar
[31. Bakirci EM, Degirmenci H, Hamur H, Gunay M, Gulhan B, Aydin M, et al. – New inflammatory markers for prediction of non-dipper blood pressure pattern in patients with essential hypertension: Serum YKL-40/Chitinase 3-like protein 1 levels and echocardiographic epicardial adipose tissue thickness. Clin Exp Hypertens. 2015;37(6):505-10. DOI: 10.3109/10641963.2015.101312210.3109/10641963.2015.1013122]Search in Google Scholar
[32. Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res. 2006;55(6):221-7. DOI: 10.1007/s00011-006-0076-y10.1007/s00011-006-0076-y]Open DOISearch in Google Scholar
[33. Vermehren-Schmaedick A, Jenkins VK, Hsieh HY, Brown AL, Page MP, Brooks VL, et al. Upregulation of brain-derived neurotrophic factor expression in no-dose ganglia and the lower brainstem of hypertensive rats. J Neurosci Res 2013;91(2):220–9. DOI: 10.1002/jnr.2315810.1002/jnr.23158]Open DOISearch in Google Scholar
[34. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328(3): 261–4. DOI: 10.1016/S0304-3940(02)00529-310.1016/S0304-3940(02)00529-3]Open DOISearch in Google Scholar
[35. Hojo Y, Noma S, Ohki T, Nakajima H, Satoh Y. Autonomic nervous system activity in essential hypertension: a comparison between dippers and non-dippers. J Hum Hypertens. 1997;11:665–71. DOI: 10.1038/sj.jhh.100051510.1038/sj.jhh.1000515]Open DOISearch in Google Scholar
[36. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hyper-tens. 2002;15(2 Pt1): 111–8. DOI: 10.1016/S0895-7061(01)02251-810.1016/S0895-7061(01)02251-8]Search in Google Scholar
[37. Kasselman LJ, Sideris A, Bruno C, Perez WR, Cai N, Nicoletti JN, et al. BDNF: a missing link between sympathetic dysfunction and inflammatory disease? J Neuroimmunol. 2006;175(1-2):118-27. DOI: 10.1016/j.jneuroim.2006.03.00810.1016/j.jneuroim.2006.03.00816631934]Open DOISearch in Google Scholar
[38. Kadoya M, Koyama H, Kanzaki A, Kurajoh M, Hatayama M, Shiraishi J, et al. Plasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors. PLoS One. 2014;9(8):e105977. DOI: 10.1371/journal.pone.010597710.1371/journal.pone.0105977414331625153796]Search in Google Scholar